Evidence map›Paper›PMID 27994680›Full record

ArticleJournal of Cancer2016

Association between the

Lifeng Ning, Wenwang Rao, Yaqin Yu, Xiaoli Liu, Yuchen Pan, Yuan Ma, Rui Liu, Shangchao Zhang, Hui Sun, Qiong Yu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of Cancer, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
  4. Article
  5. Article
  6. KRAS Gene Polymorphisms and their Impact on Breast Cancer Risk in an Iranian PopulationAsian Pacific journal of cancer prevention : APJCP · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Lifeng NingDepartment of Epidemiology and Biostatistics, School of Public Health, Jilin University, Changchun, Jilin Province, China.; National Research Institute for Family Planning, Beijing, China.
Wenwang RaoDepartment of Epidemiology and Biostatistics, School of Public Health, Jilin University, Changchun, Jilin Province, China.
Yaqin YuDepartment of Epidemiology and Biostatistics, School of Public Health, Jilin University, Changchun, Jilin Province, China.
Xiaoli LiuJilin Provincial Key Laboratory of Surgical Translational Medicine, Department of Thyroid and Parathyroid Surgery, China-Japan Union Hospital, Jilin University, Changchun, Jilin Province, China.
Yuchen PanDepartment of Epidemiology and Biostatistics, School of Public Health, Jilin University, Changchun, Jilin Province, China.
Yuan MaDepartment of Epidemiology and Biostatistics, School of Public Health, Jilin University, Changchun, Jilin Province, China.
Rui LiuDepartment of Epidemiology and Biostatistics, School of Public Health, Jilin University, Changchun, Jilin Province, China.
Shangchao ZhangDepartment of Epidemiology and Biostatistics, School of Public Health, Jilin University, Changchun, Jilin Province, China.
Hui SunJilin Provincial Key Laboratory of Surgical Translational Medicine, Department of Thyroid and Parathyroid Surgery, China-Japan Union Hospital, Jilin University, Changchun, Jilin Province, China.
Qiong YuDepartment of Epidemiology and Biostatistics, School of Public Health, Jilin University, Changchun, Jilin Province, China.
Jilin University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several studies have reported the association between MAPK signaling pathway gene polymorphisms and papillary thyroid carcinoma (PTC).

Indexed as

KRASmolecular epidemiology.papillary thyroid carcinomapolymorphisms

Identifiers

PMID27994680
PMCPMC5166553
OpenAlexW2565014508

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.